Fundraising Fox
Gibson Oncology
Miami, US · Delaware LLC
Find your way into Gibson Oncology
Sign up to see every warm intro you have to Gibson Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gibson Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gibson Oncology develops innovative therapies for glioblastoma and other brain tumors. The company's leadership team brings extensive expertise in drug discovery and development, with a track record of creating over a billion dollars in new companies and approved cancer treatments.
Founders & leadership
CS
Clifford SolomonCo-Founder and Chief Medical OfficerClifford Solomon is a neurosurgeon with over 35 years of clinical experience and co-founder and chief medical officer of Gibson Oncology, which develops therapies for glioblastoma and brain tumors. He holds patents for biomedical devices developed under Solomon Brothers Technologies and has led neurosurgery programs at major academic medical centers.
TS
Theodore SolomonChief Financial OfficerTheodore Solomon is Executive Officer and Director at Gibson Oncology, which develops therapies for glioblastoma and other brain tumors. He previously served as President at Solomon Brothers LLC and brings experience in financial management and healthcare strategy.
Board
MB
Mark BaganzBoard director
MC
Mark CushmanBoard director
MR
Mark RogersBoard director
Reported raises · per SEC filings
Form D private placements$4M disclosed across 2 rounds · 2020–2025
▶$250KraisedJul 2025 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark CushmanDirector
- Clifford SolomonExecutive Officer, Director
- Elizabeth RogersExecutive Officer, Director
- Mark RogersDirector
- Theodore SolomonExecutive Officer, Director
- Randall RiggsExecutive Officer, Director
- Mark BaganzDirector
- Offering amount
- $1.5M
- Amount sold
- $250K
- First sale
- Jul 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedOct 2024 · 8 investors · BiotechnologyRule 506(b)
▶$3.8MraisedOct 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Clifford SolomonExecutive Officer, Director
- Randall RiggsExecutive Officer, Director
- Elizabeth RogersExecutive Officer, Director
- Mark BaganzDirector
- Theodore SolomonExecutive Officer, Director
- Mark CushmanDirector
- Mark RogersDirector
- Offering amount
- $4.7M
- Amount sold
- $3.8M
- First sale
- Apr 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Gibson Oncology do?
- Gibson Oncology develops innovative therapies for glioblastoma and other brain tumors. The company's leadership team brings extensive expertise in drug discovery and development, with a track record of creating over a billion dollars in new companies and approved cancer treatments.
- How much funding has Gibson Oncology raised?
- Gibson Oncology has disclosed $4M raised across 2 rounds.
- Where is Gibson Oncology headquartered?
- Gibson Oncology is headquartered in Miami, US.